Bernadou A, Blanc C M, James J M, Dao C, Zittoun R, Bilski-Pasquier G
Nouv Presse Med. 1978 Mar 11;7(10):807-12.
Criteria reputed to be of grave prognostic significance were studied in 94 patients suffering from Hodgkin's disease at stages I and II, after laparotomy and splenectomy. The parameters studied (age, general signs, histological type, mediastinal involvement) are less prognostic factors than indications of unrecognised extension of the disease: almost 1/3 of unrecognised lesions in the presence of one of the criteria; almost 2/3 with two or more. Exploratory laparotomy revealed lesions unsuspected on the basis of clinical evaluation only in 10% of patients with no criteria of poor prognosis. The long term prognosis of the disease depends, in fact, not upon the existence of these criteria but upon the method used in initial treatment. Five year survival and cure rates are significantly better in patients treated with combined polychemotherapy (MOPP) and radiotherapy than in those treated with radiotherapy alone. These results would indicate that routine laparotomy should be abandoned in patients with a localised clinical staging if it is decided to begin treatment with a combination of radiotherapy and chemotherapy. So-called prognostic factors could then be used simply to vary the intensity of the treatment prescribed.
对94例I期和II期霍奇金病患者在剖腹术和脾切除术后,研究了被认为具有严重预后意义的标准。所研究的参数(年龄、一般体征、组织学类型、纵隔受累情况)与其说是预后因素,不如说是疾病未被识别的扩展的指标:在存在一项标准的情况下,近1/3的病变未被识别;在存在两项或更多标准的情况下,近2/3的病变未被识别。仅根据临床评估未怀疑有病变的探索性剖腹术,在无预后不良标准的患者中仅占10%。事实上,该疾病的长期预后并不取决于这些标准的存在,而是取决于初始治疗所采用的方法。联合多药化疗(MOPP)和放疗治疗的患者的五年生存率和治愈率显著高于单纯放疗治疗的患者。这些结果表明,如果决定开始采用放疗和化疗联合治疗,对于临床分期为局限性的患者应放弃常规剖腹术。那么所谓的预后因素可简单用于改变所规定治疗的强度。